Blog

VRC 610: Phase I Safety and Pharmacokinetics Study to Evaluate a Human Monoclonal Antibody (MAB) VRC-HIVMAB095-00-AB (10E8VLS) Administered Alone or Concurrently With MAB VRC- HIVMAB075-00-AB (VRC07-523LS) Via Subcutaneous Injection in Healthy Adults

Condition:   Healthy Adult Immune Response
Interventions:   Biological: VRC-HIVMAB95-00-AB (10E8VLS);   Biological: VRC-MAB075-00-AB (VRC07-523LS)
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
ClinicalTrials.gov: Womens_Health | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 21, 2018 / by / in
VRC 610: Phase I Safety and Pharmacokinetics Study to Evaluate a Human Monoclonal Antibody (MAB) VRC-HIVMAB095-00-AB (10E8VLS) Administered Alone or Concurrently With MAB VRC- HIVMAB075-00-AB (VRC07-523LS) Via Subcutaneous Injection in Healthy Adults

Condition:   Healthy Adult Immune Response
Interventions:   Biological: VRC-HIVMAB95-00-AB (10E8VLS);   Biological: VRC-MAB075-00-AB (VRC07-523LS)
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 21, 2018 / by / in
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Condition:   Pancreatic Cancer
Interventions:   Drug: FOLFIRINOX;   Drug: Losartan;   Drug: Nivolumab;   Radiation: SBRT;   Procedure: Surgery
Sponsors:   Massachusetts General Hospital;   Bristol-Myers Squibb;   Stand Up To Cancer
Not yet recruiting
ClinicalTrials.gov: Pancreatic | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 21, 2018 / by / in